Particularităţile clinice şi eficacitatea tratamentului tuberculozei pulmonare la bolnavii HIV-infectaţi

Ustian Aurelia; Zbanţ Alexandru; Boblic Rodica; Ivanoglo Alexandru; Paladi Carmina; Demişcan Galina; Stoian Vladimir

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

864

Ultima descărcare din IBN:
2016-06-03 12:41

SM ISO690:2012

USTIAN, Aurelia, ZBANŢ, Alexandru, BOBLIC, Rodica, IVANOGLO, Alexandru, PALADI, Carmina, DEMIŞCAN, Galina, STOIAN, Vladimir. Particularităţile clinice şi eficacitatea tratamentului tuberculozei pulmonare la bolnavii HIV-infectaţi. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2011, nr. 4(32), pp. 154-158. ISSN 1857-0011.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale

Numărul 4(32) / 2011 / ISSN 1857-0011

Particularităţile clinice şi eficacitatea tratamentului tuberculozei pulmonare la bolnavii HIV-infectaţi

Pag. 154-158

Ustian Aurelia, Zbanţ Alexandru, Boblic Rodica, Ivanoglo Alexandru, Paladi Carmina, Demişcan Galina, Stoian Vladimir

Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“

Disponibil în IBN: 29 noiembrie 2013

Descarcă PDF

Rezumat

Au fost studiate particularităţile clinice ale 135 din cazuri de tuberculoză la HIV-infectaţi afl aţi la tratament în spitalul municipal de tuberculoză în anii 2006-2010. Au predominat bărbaţii (67,4%), vârsta între 20-40 ani (80,0%). În 53,3 % din cazuri tuberculoza s-a dezvoltat pe fonul infecţiei HIV, în 10% tuberculoza a fost prima boală, iar în 28,1% ambele maladii au fost depistate în acelaşi timp. Pe parcursul tratamentului 62,0% din pacienţi au decedat, iar succesul tratamentului este de 22,4%.

Progressive Pulmonary Tuberculosis in HIV-infected patients The clinical features of 135 cases of tuberculosis in HIV-infected patients have been studied. All patients were treated at Municipal Hospital in 2006-2010. Men predominated (67,4%), aged between 20-40 years (80,0). Tuberculosis developed on the background of HIVinfection in 53,3% cases, tuberculosis like fi rst disease was in 10% of cases, in 28,1% of cases both of the diseases were diagnosed simultaneously. During therapy 62,0% of patients died, and treatment success is 22,4%.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-12254</cfResPublId>
<cfResPublDate>2011-10-04</cfResPublDate>
<cfVol>32</cfVol>
<cfIssue>4</cfIssue>
<cfStartPage>154</cfStartPage>
<cfISSN>1857-0011</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/12254</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Particularităţile clinice şi eficacitatea tratamentului tuberculozei pulmonare la bolnavii HIV-infectaţi</cfTitle>
<cfAbstr cfLangCode='RO' cfTrans='o'>Au fost studiate particularităţile clinice ale 135 din
cazuri de tuberculoză la HIV-infectaţi afl aţi la tratament
în spitalul municipal de tuberculoză în anii 2006-2010.
Au predominat bărbaţii (67,4%), vârsta între 20-40 ani
(80,0%). În 53,3 % din cazuri tuberculoza s-a dezvoltat pe
fonul infecţiei HIV, în 10% tuberculoza a fost prima boală,
iar în 28,1% ambele maladii au fost depistate în acelaşi
timp. Pe parcursul tratamentului 62,0% din pacienţi au
decedat, iar succesul tratamentului este de 22,4%.</cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'>Progressive Pulmonary Tuberculosis in HIV-infected
patients
The clinical features of 135 cases of tuberculosis
in HIV-infected patients have been studied. All patients
were treated at Municipal Hospital in 2006-2010. Men
predominated (67,4%), aged between 20-40 years (80,0).
Tuberculosis developed on the background of HIVinfection
in 53,3% cases, tuberculosis like fi rst disease was
in 10% of cases, in 28,1% of cases both of the diseases
were diagnosed simultaneously. During therapy 62,0% of
patients died, and treatment success is 22,4%.</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-12096</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12115</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-33008</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-43425</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-33009</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-33010</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-33011</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-12096</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12096-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Ustian</cfFamilyNames>
<cfFirstNames>Aurelia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12115</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12115-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Zbanţ</cfFamilyNames>
<cfFirstNames>Alexandru</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-33008</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-33008-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Boblic</cfFamilyNames>
<cfFirstNames>Rodica</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-43425</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-43425-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Ivanoglo</cfFamilyNames>
<cfFirstNames>Alexandru</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-33009</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-33009-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Paladi</cfFamilyNames>
<cfFirstNames>Carmina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-33010</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-33010-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Demişcan</cfFamilyNames>
<cfFirstNames>Galina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-33011</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-33011-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Stoian</cfFamilyNames>
<cfFirstNames>Vladimir</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>